Popular genetics company 23andMe is partnering up with drug giant GlaxoSmithKline to use people’s DNA to develop medical treatments, the company announced in a blog post yesterday (July 25).
The post 23andMe Is Sharing Its 5 Million Clients’ Genetic Data with Drug Giant GlaxoSmithKline appeared first on Scout SEO- Melbourne Internet Marketing.
from Innovation and Digital Marketing https://www.livescience.com/63173-23andme-partnership-glaxosmithkline.html?utm_source=rss&utm_medium=rss
No comments:
Post a Comment